Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina

Arch Ophthalmol. 2005 Nov;123(11):1563-9. doi: 10.1001/archopht.123.11.1563.

Abstract

Objective: To investigate the clinical, histologic, and electroretinographic effects of intravitreal injection of triamcinolone acetonide suspension in the rabbit retina.

Methods: Three groups of 6 rabbits each received intravitreal injections. Group 1 received 4 mg of triamcinolone acetonide, group 2 received an equal volume (0.1 mL) of the corticosteroid supernatant, and group 3 received 4 mg of triamcinolone acetonide with the supernatant replaced with balanced salt solution. Uninjected left eyes served as controls. Electroretinograms were obtained at baseline and at 3 to 4 and 6 to 7 days after injection of triamcinolone. Enucleated eyes were examined histologically.

Results: Ocular examination revealed no differences among the 3 groups. When subjected to stimulation with moderate to high flash intensities, eyes that had received intravitreal injections of triamcinolone (groups 1 and 3) had a 10% to 25% increase in dark-adapted a- and b-wave electroretinographic amplitudes. No histologic differences were observed between injected and control eyes.

Conclusions: Intravitreal injection of 4 mg of triamcinolone acetonide does not cause a toxic reaction in the rabbit retina after 7 days. Triamcinolone therapy may augment the rod-driven electroretinographic responses, suggesting a mechanism by which visual function may improve. Clinical Relevance Evaluation of the toxic effects of triamcinolone is useful because of increased applications of intravitreal injection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dark Adaptation
  • Electroretinography / drug effects*
  • Glucocorticoids / toxicity*
  • Injections
  • Photic Stimulation
  • Rabbits
  • Retina / drug effects*
  • Retina / physiology
  • Triamcinolone Acetonide / toxicity*
  • Vision, Ocular / drug effects
  • Vision, Ocular / physiology
  • Vitreous Body

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide